Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?

Journal of the American Society of Nephrology

Volumn 26, Issue 3, 2015, Pages 754-764

  Turenne, Marc N ^a   Cope, Elizabeth L ^a   Porenta, Shannon ^a,b   Mukhopadhyay, Purna ^a   Fuller, Douglas S ^a   Pearson, Jeffrey M ^a   Dahlerus, Claudia ^a,c   Lantz, Brett ^a,c   Tentori, Francesca ^a   Robinson, Bruce M ^a  

^a ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^b Catholic Health East Trinity Health   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CINACALCET; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; TRANSFERRIN; VITAMIN D; ANTIANEMIC AGENT;

ANEMIA; ARTICLE; CROSS-SECTIONAL STUDY; HEALTH CARE POLICY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSURANCE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MEDICARE; MINERAL METABOLISM; PARATHYROID HORMONE BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; RACE DIFFERENCE; AFRICAN AMERICAN; AGED; CHRONIC KIDNEY FAILURE; COMPLICATION; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; HEALTH CARE DISPARITY; MALE; MIDDLE AGED; RACISM; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; AGED; ANEMIA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTHCARE DISPARITIES; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE PAYMENT SYSTEM; RACISM; REGRESSION ANALYSIS; RENAL DIALYSIS; UNITED STATES;

EID: 84924059652     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013111232     Document Type: Article

References (29)

1. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare program; end-stage renal disease prospective payment system. Final rule. Fed Regist 75: 49029-49214, 2010
2. Roach JL, Turenne MN, Hirth RA, Wheeler JRC, Sleeman KS, Messana JM: Using race as a case-mix adjustment factor in a renal dialysis payment system: Potential and pitfalls. Am J Kidney Dis 56: 928-936, 2010
3. U.S. Government Accountability Office: End-stage Renal Disease:CMS Should Monitor Access to and Quality of Dialysis Care Promptly after Implementation of New Bundled Payment System, Washington, DC, U.S. Government Accountability Office, 2010
4. Ishani A, Guo H, Arneson TJ, Gilbertson DT, Mau L-W, Li S, Dunning S, Collins AJ: Possible effects of the new Medicare reimbursement policy on African Americans with ESRD. J Am Soc Nephrol 20: 1607-1613, 2009
5. Lacson E Jr, Rogus J, Teng M, Lazarus JM, Hakim RM: The association of race with erythropoietin dose in patients on long-term hemodialysis. Am J Kidney Dis 52: 1104-1114, 2008
6. Lea JP, Norris K, Agodoa L: The role of anemia management in improving outcomes for African-Americans with chronic kidney disease. Am J Nephrol 28: 732-743, 2008
7. US Food and Drug Administration: FDA Drug Safety Communication: Modified dosing recommendations to improve the safe use of Erythropoiesis-Stimulating Agents (ESAs) in chronic kidney disease. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm259639.htm Accessed July 30, 2013.
8. Fuller DS, Pisoni RL, Bieber BA, Gillespie BW, Robinson BM: The DOPPS Practice Monitor for US dialysis care: Trends through December 2011. Am J Kidney Dis 61: 342-346, 2013
9. Hirth RA, Turenne MN, Wheeler JR, Nahra TA, Sleeman KK, Zhang W, Messana JA: The initial impact of Medicare's new prospective payment system for kidney dialysis. Am J Kidney Dis 62: 662-669, 2013
10. Kucirka LM, Grams ME, Lessler J, Hall EC, James N, Massie AB, Montgomery RA, Segev DL: Association of race and age with survival among patients undergoing dialysis. JAMA 306: 620-626, 2011
11. Brunelli SM, Monda KL, Burkart JM, Gitlin M, Neumann PJ, Park GS, Symonian-Silver M, Yue S, Bradbury BD, Rubin RJ: Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS). Am J Kidney Dis 61: 947-956, 2013
12. Gupta A, Kallenbach LR, Zasuwa G, Divine GW: Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 11: 330-334, 2000
13. Moe SM, Drüeke TB, Block GA; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113: S1-S130, 2009
14. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
15. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006
16. Slinin Y, Foley RN, Collins AJ: Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16: 1788-1793, 2005
17. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67: 1179-1187, 2005
18. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D; CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098, 2006
19. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A; CREATE Investigators: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084, 2006
20. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032, 2009
21. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare program; end-stage renal disease prospective payment system and quality incentive program; ambulance fee schedule; durable medical equipment; and competitive acquisition of certain durable medical equipment prosthetics, orthotics and supplies. Final rule. Fed Regist 76: 70228-70316, 2011
22. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Cavazos D, Heydari A, Kahan BD: Influence of race on crossmatch outcome and recipient eligibility for transplantation. Transplantation 53: 64-67, 1992
23. Alexander GC, Sehgal AR: Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA 280: 1148-1152, 1998
24. Ayanian JZ, Cleary PD, Weissman JS, Epstein AM: The effect of patients' preferences on racial differences in access to renal transplantation. N Engl JMed 341: 1661-1669, 1999
25. Epstein AM, Ayanian JZ, Keogh JH, Noonan SJ, Armistead N, Cleary PD, Weissman JS, David-Kasdan JA, Carlson D, Fuller J, Marsh D, Conti RM: Racial disparities in access to renal transplantation-clinically appropriate or due to underuse or overuse? N Engl J Med 343: 1537-1544, 2, 1537, 2000
26. Patzer RE, Amaral S, Wasse H, Volkova N, Kleinbaum D, McClellan WM: Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol 20: 1333-1340, 2009
27. Hirth RA, Turenne MN, Wilk AS, Wheeler JR, Sleeman KK, Zhang W, Paul MA, Nahra TA, Messana JM. Blood transfusion practices in dialysis patients in a dynamic regulatory environment [published online ahead of print February 19, 2014]. Am J Kidney Dis doi: 10.1053/j.ajkd.2014.01.011
28. Arbor Research Collaborative for Health: DOPPS Practice Monitor. Available at: http://www.dopps.org/DPM/Default.aspx. Accessed February 28, 2013.
29. Robinson B, Fuller D, Zinsser D, Albert J, Gillespie B, Tentori F, Turenne M, Port F, Pisoni R: The Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor: Rationale and methods for an initiative to monitor the new US bundled dialysis payment system. Am J Kidney Dis 57: 822-831, 2011